159 related articles for article (PubMed ID: 21029109)
1. Transfusion practice in hip arthroplasty--a nationwide study.
Jans Ø; Kehlet H; Hussain Z; Johansson PI
Vox Sang; 2011 May; 100(4):374-80. PubMed ID: 21029109
[TBL] [Abstract][Full Text] [Related]
2. [Transfusion practice in total hip arthroplasty in Danish departments of orthopaedic surgery].
Pedersen AB; Mehnert F; Overgaard S; Møller B; Johnsen SP
Ugeskr Laeger; 2009 Mar; 171(12):973-7. PubMed ID: 19284915
[TBL] [Abstract][Full Text] [Related]
3. Transfusion-related mortality after primary hip arthroplasty--an analysis of mechanisms and confounders.
Jans Ø; Kehlet H; Johansson PI
Vox Sang; 2012 Nov; 103(4):301-8. PubMed ID: 22519366
[TBL] [Abstract][Full Text] [Related]
4. Transfusion rates are increasing following total hip arthroplasty: risk factors and outcomes.
Browne JA; Adib F; Brown TE; Novicoff WM
J Arthroplasty; 2013 Sep; 28(8 Suppl):34-7. PubMed ID: 23896359
[TBL] [Abstract][Full Text] [Related]
5. Possible guidelines for autologous red blood cell donations before total hip arthroplasty based on the surgical blood order equation.
Nuttall GA; Santrach PJ; Oliver WC; Ereth MH; Horlocker TT; Cabanela ME; Trousdale RT; Schroeder DR
Mayo Clin Proc; 2000 Jan; 75(1):10-7. PubMed ID: 10630751
[TBL] [Abstract][Full Text] [Related]
6. Inpatient interdisciplinary rehabilitation after total hip arthroplasty surgery: a comparison of revision and primary total hip arthroplasty.
Walker WC; Keyser-Marcus LA; Cifu DX; Chaudhri M
Arch Phys Med Rehabil; 2001 Jan; 82(1):129-33. PubMed ID: 11239299
[TBL] [Abstract][Full Text] [Related]
7. Postoperative use of bisphosphonates and risk of revision after primary total hip arthroplasty: a nationwide population-based study.
Thillemann TM; Pedersen AB; Mehnert F; Johnsen SP; Søballe K
Bone; 2010 Apr; 46(4):946-51. PubMed ID: 20102756
[TBL] [Abstract][Full Text] [Related]
8. Implant survival after primary total hip arthroplasty due to childhood hip disorders: results from the Danish Hip Arthroplasty Registry.
Thillemann TM; Pedersen AB; Johnsen SP; Søballe K;
Acta Orthop; 2008 Dec; 79(6):769-76. PubMed ID: 19085493
[TBL] [Abstract][Full Text] [Related]
9. Red blood cell transfusions for elective hip and knee arthroplasty: opportunity to improve quality of care and documentation.
Cook SS; Cangialose CB; Sieburg DM; Kieszak SM; Boudreau R; Hoffman LH; Elward KS; Ballard DJ
Clin Perform Qual Health Care; 1999; 7(1):5-16. PubMed ID: 10351595
[TBL] [Abstract][Full Text] [Related]
10. [Mannheim concept of preoperative autologous blood donation and perioperative autologous blood transfusion in hip endoprosthesis surgery].
Lorentz A; Konermann W; Kellenbenz C; Heine T; Zimmermann G; Segiet W; Jani L
Z Orthop Ihre Grenzgeb; 2000; 138(4):311-7. PubMed ID: 11033898
[TBL] [Abstract][Full Text] [Related]
11. Perioperative transfusion management in patients with sickle cell anaemia undergoing a total hip arthroplasty. Is there a role of red-cell exchange transfusion? A retrospective study in the CHU of Fort-de-France Martinique.
Ould Amar K; Rouvillain JL; Loko G
Transfus Clin Biol; 2013 Mar; 20(1):30-4. PubMed ID: 23522689
[TBL] [Abstract][Full Text] [Related]
12. Inferior outcome after intraoperative femoral fracture in total hip arthroplasty: outcome in 519 patients from the Danish Hip Arthroplasty Registry.
Thillemann TM; Pedersen AB; Johnsen SP; Søballe K
Acta Orthop; 2008 Jun; 79(3):327-34. PubMed ID: 18622835
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin is an effective clinical modality for reducing RBC transfusion in joint surgery.
Karkouti K; McCluskey SA; Evans L; Mahomed N; Ghannam M; Davey R
Can J Anaesth; 2005 Apr; 52(4):362-8. PubMed ID: 15814749
[TBL] [Abstract][Full Text] [Related]
14. A randomized comparison of transfusion triggers in elective orthopaedic surgery using leucocyte-depleted red blood cells.
So-Osman C; Nelissen R; Te Slaa R; Coene L; Brand R; Brand A
Vox Sang; 2010 Jan; 98(1):56-64. PubMed ID: 19656349
[TBL] [Abstract][Full Text] [Related]
15. Risk for postoperative infection after transfusion of white blood cell-filtered allogeneic or autologous blood components in orthopedic patients undergoing primary arthroplasty.
Innerhofer P; Klingler A; Klimmer C; Fries D; Nussbaumer W
Transfusion; 2005 Jan; 45(1):103-10. PubMed ID: 15647025
[TBL] [Abstract][Full Text] [Related]
16. [Venous thromboembolism prophylaxis after total hip arthroplasty].
Kučera T; Malý R; Urban K; Sponer P
Acta Chir Orthop Traumatol Cech; 2011; 78(2):101-5. PubMed ID: 21575551
[TBL] [Abstract][Full Text] [Related]
17. [Early primary total hip arthroplasty for acetabular fractures in elderly patients].
Simko P; Braunsteiner T; Vajcziková S
Acta Chir Orthop Traumatol Cech; 2006 Aug; 73(4):275-82. PubMed ID: 17026887
[TBL] [Abstract][Full Text] [Related]
18. Use of diuretics and risk of implant failure after primary total hip arthroplasty: a nationwide population-based study.
Thillemann TM; Pedersen AB; Mehnert F; Johnsen SP; Søballe K
Bone; 2009 Sep; 45(3):499-504. PubMed ID: 19410667
[TBL] [Abstract][Full Text] [Related]
19. Retransfusion of filtered shed blood in everyday orthopaedic practice.
Moonen AF; Thomassen BJ; van Os JJ; Verburg AD; Pilot P
Transfus Med; 2008 Dec; 18(6):355-9. PubMed ID: 19140818
[TBL] [Abstract][Full Text] [Related]
20. Patient factors affecting autologous and allogeneic blood transfusion rates in total hip arthroplasty.
Marx RG; Wotherspoon S; Stephens D; Davey JR
Am J Orthop (Belle Mead NJ); 2001 Dec; 30(12):867-71. PubMed ID: 11771798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
